All Online

1 - 3 of 3 results


Active filters

Lipid Disorders (Dyslipidemia)

There are several challenges in the management of T2DM that faces clinicians today in the real-world setting. This case study is designed to improve clinician competence and practice.

Inhibitors of the PCSK9 protein represent an important new therapeutic class for patients with familiar hypercholesterolemia or established CVD who require further LDL-C lowering beyond what statins can provide. This Case Curriculum illustrates two patient scenarios for the use of PCSK9 inhibitors, and reviews selection of patients who require more intensive LDL-C lowering and clinical efficacy and safety data for these novel agents.